Terns Pharmaceuticals, Inc.
TERNDelisted May 5, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831363
Terns Pharmaceuticals, Inc. was delisted on May 5, 2026; its insiders filed their last Form 4 on May 5, 2026; 317 institutions reported holding it in 13F filings for Q1 2026, worth $6.56B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q3 2021
Institutional positions in Terns Pharmaceuticals, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- −2 vs. Q2 2021
- Shares held
- 16.7M
- +103.8K (+0.6%) vs. Q2 2021
- Total value
- $174.3M
- −$29.5M (−14.5%) vs. Q2 2021
- New holders
- 3
- 17 more added
- Sold out
- 5
- 7 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TERN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $75.4K |
| Q1 2026 | 317 | $6.56B |
| Q4 2025 | 248 | $4.95B |
| Q3 2025 | 141 | $665.7M |
| Q2 2025 | 130 | $310.0M |
| Q1 2025 | 138 | $229.4M |
| Q4 2024 | 157 | $477.2M |
| Q3 2024 | 156 | $663.1M |
| Q2 2024 | 126 | $446.7M |
| Q1 2024 | 112 | $414.8M |
| Q4 2023 | 103 | $412.7M |
| Q3 2023 | 93 | $310.4M |
| Q2 2023 | 103 | $505.0M |
| Q1 2023 | 79 | $630.2M |
| Q4 2022 | 65 | $506.2M |
| Q3 2022 | 45 | $178.1M |
| Q2 2022 | 42 | $36.5M |
| Q1 2022 | 44 | $50.0M |
| Q4 2021 | 37 | $116.7M |
| Q3 2021 | 34 | $174.3M |
| Q2 2021 | 36 | $203.8M |
| Q1 2021 | 42 | $393.7M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Terns Pharmaceuticals, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 15 | $0 | 0.00% | +15 | New |
| Public Employees Retirement System of Ohio | 400 | $4.00K | 0.00% | +400 | New |
| Ameritas Investment Partners, Inc. | 708 | $7.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 759 | $8.00K | 0.00% | −421−35.7% | Reduced |
| Legal & General Group Plc | 1,279 | $13.0K | 0.00% | +400+45.5% | Added |
| Citigroup Inc | 1,592 | $17.0K | 0.00% | +1,177+283.6% | Added |
| Royal Bank of Canada | 1,751 | $18.0K | 0.00% | +1,155+193.8% | Added |
| California State Teachers Retirement System | 4,639 | $48.0K | 0.00% | −7,399−61.5% | Reduced |
| Bank of America Corp | 5,132 | $53.0K | 0.00% | +157+3.2% | Added |
| JPMorgan Chase & Co | 5,254 | $55.0K | 0.00% | −6,165−54.0% | Reduced |
| New York State Common Retirement Fund | 5,874 | $61.0K | 0.00% | +5+0.1% | Added |
| American International Group, Inc. | 7,507 | $78.0K | 0.00% | +2,624+53.7% | Added |
| Deutsche Bank AG | 8,471 | $88.0K | 0.00% | +2,577+43.7% | Added |
| S&T Bank | 10,000 | $104.0K | 0.02% | +10,000 | New |
| Nuveen Asset Management, LLC | 14,237 | $150.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 26,044 | $271.0K | 0.00% | −787−2.9% | Reduced |
| Bank of New York Mellon Corp | 27,513 | $287.0K | 0.00% | +4,227+18.2% | Added |
| Charles Schwab Investment Management Inc | 31,543 | $329.0K | 0.00% | +10,184+47.7% | Added |
| Cowen and Company, LLC | 85,000 | $886.0K | 0.04% | 00.0% | Unchanged |
| Caas Capital Management LP | 85,851 | $895.0K | 0.07% | +65,404+319.9% | Added |
| Jacobs Levy Equity Management, Inc | 87,534 | $912.0K | 0.01% | +69,884+395.9% | Added |
| Northern Trust Corp | 116,916 | $1.22M | 0.00% | +30,133+34.7% | Added |
| State Street Corp | 150,340 | $1.57M | 0.00% | +21,637+16.8% | Added |
| Geode Capital Management, LLC | 193,336 | $2.01M | 0.00% | +50,267+35.1% | Added |
| Samsara BioCapital, LLC | 289,068 | $3.01M | 0.50% | 00.0% | Unchanged |
| Vanguard Group Inc | 440,672 | $4.59M | 0.00% | +24,942+6.0% | Added |
| BlackRock Inc. | 602,556 | $6.28M | 0.00% | +164,952+37.7% | Added |
| Antara Capital LP | 774,834 | $8.07M | 1.59% | −1,100−0.1% | Reduced |
| Matthews International Capital Management LLC | 875,068 | $9.12M | 0.55% | −196,353−18.3% | Reduced |
| Suvretta Capital Management, LLC | 1,125,736 | $11.7M | 0.20% | +600+0.1% | Added |
| Deerfield Management Company, L.P. (Series C) | 2,345,959 | $24.4M | 0.48% | 00.0% | Unchanged |
| Vivo Capital, LLC | 2,675,133 | $27.9M | 1.25% | 00.0% | Unchanged |
| FMR LLC | 2,933,162 | $30.6M | 0.00% | −89,395−3.0% | Reduced |
| OrbiMed Advisors LLC | 3,791,204 | $39.5M | 0.44% | 00.0% | Unchanged |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −18,200−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −14,769−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −11,973−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −10,308−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −60−100.0% | Sold out |